Hemostasis is characterized as a physiological process that assists in preventing & stopping bleed. This procedure comprises of three steps which are recognized as platelet plug formation, vascular spasm (vasoconstriction) and coagulation. Hemostasis valve is a specific device, generally used to reduce the risk of thromboembolism during the neuro-endovascular procedures. Additionally, hemostasis valves are also used on the wide-scale in interventional surgical procedures including percutaneous transluminal coronary angioplasty to reduce the blood loss after the interventional instrument insertion in human-vasculature. A significant increase in the incidence of heart disease has led to a sharp increase in endovascular surgeries, driving market trends. Increase in preference for hemostasis valves by the healthcare providers as they offer the efficiency of next-generation catheter & delivery systems, rise in number of coronary angiography procedures for diagnosis of heart muscles and increase in number of interventional procedures in a variety of medical specialties are likely to drive the growth of market.

Referring to the study, “Global Hemostasis Valves Market, 2021-2027” the key companies operating in the global hemostasis valves market include Teleflex Incorporated, Freudenberg Medical, Boston Scientific Corporation, Terumo Corporation, Merit Medical Systems and among others. The renowned players are implementing pioneering technologies to provide for large unmet requirements of the customers.

In terms of product type, hemostasis valves market can be categorized as hemostasis valve y-connectors, double y-connector hemostasis valves and one-handed hemostasis valves. Double Y Connector Hemostasis Valve segment holds major share in global market because of reduced side-effects of treatment and high degree of precision. In addition, based on application market can be categorized as angioplasty and angiography. The angiography segment is estimated to exhibit considerable growth rate caused by increase in number of coronary angiography procedures all over the globe during the forecast period.

Increase in number of interventional procedures, followed by rise in aging population prone to heart or cardiac disorders, growth in technological advances in hemostasis valves by manufactures and rise in incidence of chronic diseases are some major factors, which are responsible for growth of the hemostasis valves market. Apart from this, lack of skilled professionals and growth in infrastructural restrictions in healthcare facilities may impact the market. Moreover, growth in innovations in hemostasis valves & therapeutic catheter development and increase in use of minimally-invasive hemostasis valves in catheter systems are leading opportunities for market.

Based on geographic analysis, the North-America is a prevalent region in global hemostasis valves market owing to increase in prevalence of blood disorder disease, rise in proportion of interventional surgeries, increase in number of coronary artery ailments and growth in technological advancement across the region. The Asia-Pacific and Europe regions are anticipated to witness higher growth rate due to increase in prevalence of hemophilia and presence of key players over the forecast period. It is estimated that future of the global hemostasis valves market will be bright as a result of rise in demand for hemostasis valves from healthcare providers and growth in geriatric population during the forecast period.

For More Information, refer to below link:-

https://www.kenresearch.com/healthcare/medical-devices/hemostasis-valves-market/434106-91.html

Related Reports

https://www.kenresearch.com/healthcare/medical-devices/hemostasis-valves-market/313468-91.html

https://www.kenresearch.com/healthcare/medical-devices/connector-hemostasis-valves/422955-91.html

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications

[email protected]

+91-9015378249